Circumventing cancer drug resistance in the era of personalized medicine.

Cancer Discovery
Levi A Garraway, Pasi A Jänne

Abstract

All successful cancer therapies are limited by the development of drug resistance. The increase in the understanding of the molecular and biochemical bases of drug efficacy has also facilitated studies elucidating the mechanism(s) of drug resistance. Experimental approaches that can help predict the eventual clinical drug resistance, coupled with the evolution of systematic genomic and proteomic technologies, are rapidly identifying novel resistance mechanisms. In this review, we provide a historical background on drug resistance and a framework for understanding the common ways by which cancers develop resistance to targeted therapies. We further discuss advantages and disadvantages of experimental strategies that can be used to identify drug resistance mechanism(s). Increased knowledge of drug resistance mechanisms will aid in the development of effective therapies for patients with cancer. We provide a summary of current knowledge on drug resistance mechanisms and experimental strategies to identify and study additional drug resistance pathways.

References

Nov 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·J RineR W Davis
Sep 1, 1983·Cancer·J BladéE Montserrat
Oct 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E K RowinskyS H Kaufmann
Sep 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G C WishartR C Leonard
Jan 6, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D BelpommeF Sturtz
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Jul 6, 2002·Science·I Bernard Weinstein
Aug 16, 2002·The New England Journal of Medicine·George D DemetriHeikki Joensuu
Dec 4, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L A Garraway, B Chabner
Jan 1, 1963·Advances in Cancer Research·R W BROCKMAN
Feb 8, 2005·PLoS Medicine·Stanley H ZlotkinS M Ziauddin Hyder
Feb 25, 2005·The New England Journal of Medicine·Susumu KobayashiBalázs Halmos
Jul 1, 2005·Nature·Franziska MichorMartin A Nowak
Feb 3, 2006·Cancer Research·Kathryn E O'ReillyNeal Rosen
Jul 25, 2006·Nature Reviews. Cancer·Levi A Garraway, William R Sellers
Aug 15, 2006·The Journal of Clinical Investigation·Jeffrey A EngelmanPasi A Jänne
Sep 7, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael C HeinrichJonathan A Fletcher
Aug 3, 2007·The Journal of Clinical Investigation·Daniel W Sherbenou, Brian J Druker
Dec 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·James BeanWilliam Pao
Jan 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Cai-Hong YunMichael J Eck
May 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeffrey A Engelman, Pasi A Jänne
Jun 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Darren J BurgessMichael T Hemann
Oct 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael C HeinrichGeorge D Demetri
Dec 24, 2008·Nature Reviews. Cancer·Jianming ZhangNathanael S Gray
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ketan S GajiwalaGeorge D Demetri
May 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·George N NaumovJohn V Heymach
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka

❮ Previous
Next ❯

Citations

Apr 10, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·M J Duffy
Dec 20, 2013·Lancet·Douglas Hanahan
Nov 10, 2013·Nature Medicine·Curtis R Chong, Pasi A Jänne
Jan 1, 2013·Nature Reviews. Drug Discovery·Mishal N PatelBissan Al-Lazikani
Mar 16, 2013·Current Opinion in Oncology·Rodrigo DienstmannJosep Tabernero
Nov 13, 2012·PloS One·Nobuaki ShindohDavid M Weinstock
May 9, 2013·PloS One·Siau Jia WeiFarid Ghadessy
Dec 24, 2013·Trends in Pharmacological Sciences·Min HuangMeiyu Geng
Nov 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Monika A DavareBrian J Druker
Jun 27, 2012·EMBO Molecular Medicine·Nicholas A SaundersAlexander Guminski
Feb 20, 2014·Proceedings of the National Academy of Sciences of the United States of America·Luping LinTrever G Bivona
May 9, 2014·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Simonetta M Leto, Livio Trusolino
Jun 4, 2014·Current Breast Cancer Reports·Terisse BrocatoVittorio Cristini
Sep 10, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Marco RanzaniEugenio Montini
Oct 9, 2014·The New England Journal of Medicine·Nikhil WagleJochen H Lorch
Oct 9, 2014·Systematic Biology·Niko BeerenwinkelFlorian Markowetz
Jan 31, 2015·Expert Opinion on Therapeutic Targets·Bishoy M FaltasJonathan E Rosenberg
Oct 18, 2015·Methods : a Companion to Methods in Enzymology·Albert GoughMark Schurdak
Oct 3, 2015·Seminars in Cell & Developmental Biology·Maicol Mancini, Yosef Yarden
Nov 17, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Andrew J WeickhardtD Ross Camidge
Feb 2, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Fred R HirschTony S Mok
Feb 24, 2016·Small GTPases·Gorjan Hrustanovic, Trever G Bivona
Jun 17, 2016·Molecular & Cellular Oncology·Luping Lin, Trever G Bivona
Dec 15, 2015·Cell Cycle·Gorjan Hrustanovic, Trever G Bivona
Dec 23, 2015·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Yoav BinenbaumZiv Gil
Nov 10, 2015·Future Oncology·Yunhua LiuXiongbin Lu
Nov 10, 2015·Future Oncology·Katrina K AuMadhuri Koti
Mar 12, 2015·Cancer Cell·Frederick H WilsonLevi A Garraway
Jun 18, 2016·Molecular & Cellular Oncology·Joan Montero, Anthony Letai
Feb 24, 2015·Oncogene·E Pazarentzos, T G Bivona
Jan 30, 2013·The FEBS Journal·Jared J Barrott, Timothy A J Haystead
Oct 10, 2013·The Journal of Pathology·Britta Weigelt, Jorge S Reis-Filho
Jul 22, 2014·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Ida Viller TuxenUlrik Lassen
Aug 29, 2013·Biopharmaceutics & Drug Disposition·Ioannis N MelasLeonidas G Alexopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Jeffrey A Engelman, Pasi A Jänne
The New England Journal of Medicine
Keith T FlahertyJeffrey S Weber
© 2021 Meta ULC. All rights reserved